Condensed Interim Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current
Cash and cash equivalents	$ 5,371,608	$ 5,710,227
Term deposits	1,025,347	1,025,347
Accounts receivable (Note 4)	9,943,148	7,129,329
Inventories (Note 5)	12,214,651	9,502,005
Prepaid expenses	859,922	442,161
Total current assets	29,414,676	23,809,069
Property, equipment and leaseholds, net (Note 6)	4,920,019	4,931,713
Patents (Note 7)	9,589	13,699
Right of use assets (Note 3)	203,721	217,267
Intangible assets (Note 8)	2,560,000	2,600,000
Long term deposits (Note 9)	8,540	8,540
Investments (Note 10)	5,453,274	5,424,010
Goodwill (Note 8)	2,534,275	2,534,275
Deferred tax asset	12,697	12,697
Total Assets	45,116,791	39,551,270
Current
Accounts payable	1,362,779	1,283,486
Accrued liabilities	1,318,503	457,062
Deferred revenue	271,426	349,004
Income taxes payable	5,273,842	4,561,396
Short term line of credit (Note 11)	4,948,545	2,300,819
Current portion of lease liability (Note 3)	57,045	77,715
Current portion of long term debt (Note 12)	665,614	793,574
Total current liabilities	13,897,754	9,823,056
Lease liability (Note 3)	146,676	139,552
Deferred income tax liability	310,162	310,162
Long term debt (Note 12)	1,491,355	1,573,024
Total Liabilities	15,845,947	11,845,794
Stockholders’ Equity
Capital stock (Note 14) Authorized: 50,000,000 common shares with a par value of $0.001 each; 1,000,000 preferred shares with a par value of $0.01 each Issued and outstanding: 12,377,746 (December 31, 2021: 12,355,246) common shares	12,378	12,355
Capital in excess of par value	17,094,836	16,983,648
Other comprehensive loss	(733,187)	(775,730)
Accumulated earnings	10,415,419	8,882,360
Total stockholders’ equity – controlling interest	26,789,446	25,102,633
Non-controlling interests (Note 15)	2,481,398	2,602,843
Total Stockholders’ Equity	29,270,844	27,705,476
Total Liabilities and Stockholders’ Equity	$ 45,116,791	$ 39,551,270